WorthWeil

Antitrust

A Global Antitrust Blog

Healthcare

Roll-up, roll-up: What’s next for antitrust scrutiny of serial acquisition strategies?

Contributor(s)

U.S. Federal Court Deals the FTC a Loss by Crediting Merging Companies’ Failing Firm Defenses and Commitments Regarding Post-Merger Conduct

Contributor(s)

WorthWeil By The Numbers: Closing Your Complex Global Deal

Contributor(s)

Marie-Marie de
Fays

Natalia
Komorowska

Antitrust Scrutiny of “Roll Up” Strategies Heats Up as US Agencies Examine Private Equity Healthcare Deals

Contributor(s)

Michael
Moiseyev

Abuse of dominance, Compliance, Conduct

The Parent Trap: Dealing with Sponsor Liability for Antitrust Breaches by Portfolio Companies

Contributor(s)

Jenine
Hulsmann

Marie-Marie de
Fays

Client Alert: Merger Reviews of Non-Reportable M&A Deals: How Can Dealmakers Manage the Increasing Risks?

Contributor(s)

Jenine
Hulsmann

Jenny
Patroclou

Client Alert: Five Things You Should Know About Article 22

Contributor(s)